Many Cancer Drugs, Hardly Any Breakthroughs

By
Nathan
on June 6, 2010 7:52 PM |
Drug companies are rushing more cancer drugs into trials than ever before. The sequencing of the genome has led to an unprecedented explosion of new targets deep inside cancer cells, and more are being discovered every day.  Read more at blogs.forbes.com

Categories:

The views expressed in the articles on this website are the opinions of the respective author and do not reflect the views of the Karen E. Mumford Cancer Foundation or it's Board of Directors.

© 2012 Karen E. Mumford Cancer Foundation